Neurofibromatoses Type II - Pipeline Review, H1 2016 - Research and Markets
May 26 2016 - 12:32PM
Business Wire
Research and Markets has announced the addition of the
"Neurofibromatoses Type II - Pipeline Review, H1 2016" report to
their offering.
This report provides comprehensive information on the
therapeutic development for Neurofibromatoses Type II , complete
with comparative analysis at various stages, therapeutics
assessment by drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type, along with latest updates,
and featured news and press releases. It also reviews key players
involved in the therapeutic development for Neurofibromatoses Type
II and special features on late-stage and discontinued
projects.
The report enhances decision making capabilities and help to
create effective counter strategies to gain competitive advantage.
It strengthens R&D pipelines by identifying new targets and
MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Neurofibromatoses Type II Overview
- Therapeutics Development
- Pipeline Products for Neurofibromatoses Type II - Overview
- Pipeline Products for Neurofibromatoses Type II - Comparative
Analysis
- Neurofibromatoses Type II - Therapeutics under Development by
Companies
- Neurofibromatoses Type II - Therapeutics under Investigation by
Universities/Institutes
- Neurofibromatoses Type II Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Neurofibromatoses Type II - Products under Development by
Companies
- Neurofibromatoses Type II - Products under Investigation by
Universities/Institutes
- Neurofibromatoses Type II - Companies Involved in Therapeutics
Development
- Arno Therapeutics, Inc.
- CalAsia Pharmaceuticals, Inc.
- Lixte Biotechnology Holdings, Inc.
- Novartis AG
For more information visit
http://www.researchandmarkets.com/research/4k83xl/neurofibromatoses
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160526006167/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716